Award recordCONTRACT

BIOCRYST PHARMACEUTICALS INC

PIID 36F79721D0166· VA Staff Offices· NAC FEDERAL SUPPLY SCHEDULE (36F797)· 6505 · DRUGS AND BIOLOGICALS· FY2021· $0 net obligations· UEI MGXADJ6SCLJ5· NC

Description

ADM

Base award description: 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD

First action · last action
2021-05-05 · 2026-08-31
Transactions
13
First transaction's obligation
$0
Base + all options value (sum of deltas)
$1,250,000
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
999
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 13 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$1$0Base award · 2021-05-05 · this action $0 · running total $0Modification P00001 · 2021-10-14 · this action $0 · running total $0Modification P00002 · 2021-10-28 · this action $0 · running total $0Modification P00003 · 2021-12-02 · this action $0 · running total $0Modification P00004 · 2022-12-12 · this action $0 · running total $0Modification P00005 · 2023-07-25 · this action $0 · running total $0Modification P00006 · 2023-10-27 · this action $0 · running total $0Modification P00007 · 2023-11-16 · this action $0 · running total $0Modification P00008 · 2024-11-21 · this action $0 · running total $0Modification P00009 · 2025-09-04 · this action $0 · running total $0Modification P00010 · 2025-12-02 · this action $0 · running total $0Modification P00011 · 2026-05-11 · this action $0 · running total $0Modification P00012 · 2026-08-31 · this action $0 · running total $0
  • Base2021-05-05+$0= $0
  • Mod P000012021-10-14+$0= $0
  • Mod P000022021-10-28+$0= $0
  • Mod P000032021-12-02+$0= $0
  • Mod P000042022-12-12+$0= $0
  • Mod P000052023-07-25+$0= $0
  • Mod P000062023-10-27+$0= $0
  • Mod P000072023-11-16+$0= $0
  • Mod P000082024-11-21+$0= $0
  • Mod P000092025-09-04+$0= $0
  • Mod P000102025-12-02+$0= $0
  • Mod P000112026-05-11+$0= $0
  • Mod P000122026-08-31+$0= $0
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2021-05-05+$0$065 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2021-10-14+$0$0ADMIN / NEW IFF SALES CONTACT
Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2021-10-28+$0$0ADMINISTRATION CHANGE (POC)
Mod P00003· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2021-12-02+$0$0PUBLIC LAW 2022
Mod P00004· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2022-12-12+$0$0PUBLIC LAW 2023
Mod P00005· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2023-07-25+$0$0ADMINISTRATION CHANGE (POC)
Mod P00006· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2023-10-27+$0$0ADMINISTRATION CHANGE (FSS SALES
Mod P00007· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2023-11-16+$0$0PHARMACEUTICALS
Mod P00008· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2024-11-21+$0$0PUBLIC LAW 2025
Mod P00009· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2025-09-04+$0$0ADM
Mod P00010· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2025-12-02+$0$0PUBLIC LAW 2026
Mod P00011· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2026-05-11+$0$0CONTRACT EXTENSION
Mod P00012· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2026-08-31+$0$0ADM

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI MGXADJ6SCLJ5)

AwardOffice · PSC / listingNet obligationsFY
36E79726A0015NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36C24926F0152249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$30,293FY2026
36C26026F0294260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$151,465FY2026
36C26026F0006260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$360,000FY2026
36C26025F0296260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$29,408FY2025
36C26025F0070260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$242,987FY2025

Other recipients under 6505 from NAC FEDERAL SUPPLY SCHEDULE (36F797) (most recent first)

AwardRecipientOfficeNet obligationsFY
36F79726D058EREVOLUTION MEDICINES, INC.NAC FEDERAL SUPPLY SCHEDULE (36F797)$0FY2026
36F79726D0172LUNDBECK LLCNAC FEDERAL SUPPLY SCHEDULE (36F797)$0FY2026
36F79726D0195MILESTONE PHARMACEUTICALS USA, INC.NAC FEDERAL SUPPLY SCHEDULE (36F797)$0FY2026
36F79726D0165RECKITT BENCKISER LLCNAC FEDERAL SUPPLY SCHEDULE (36F797)$0FY2026
36F79726D0118OMEROS CORPORATIONNAC FEDERAL SUPPLY SCHEDULE (36F797)$0FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36F79721D0166_3600 · retrieved 2026-09-26.